CP-2

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameCP-2
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmyloid beta-protein precursor inhibitorsGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptorAmyloid beta-protein precursor
Therapy Area/IndicationsDiabetes MellitusAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAfaSci Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of California DavisAfaSci IncKansas State University
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A